Logo

American Heart Association

  2
  0


Final ID: MDP1082

Long-Term Cumulative LDL-C Exposure and ASCVD Events in Young Adults with CAC=0: Insights from the CARDIA Study

Abstract Body (Do not enter title and authors here):
Introduction
Cumulative exposure to LDL-C over time is independently associated with incident atherosclerotic cardiovascular disease (ASCVD), while the absence of coronary artery calcium (CAC) is associated with a low risk of ASCVD events regardless of baseline LDL-C. Whether cumulative LDL-C exposure influences clinical risk stratification in individuals with CAC=0 is unknown.

Objectives
To assess whether cumulative LDL-C exposure in young adults with CAC=0 was associated with incident ASCVD events or future conversion to CAC>0.

Methods
This analysis included Coronary Artery Risk Development in Young Adults (CARDIA) participants who underwent CAC scans at year 15 (Y15) (n=3043) or Y25 (n=3189) with measures of LDL-C from Y0 (baseline), 2, 5, 7, 10, 15, 20, 25, 30, and 35. Of those with CAC measured at Y15 and Y25, 2734 (89.9%) and 2282 (71.6%) had CAC=0, respectively. Cumulative LDL-C exposure was calculated using area under the curve (LDL-AUC) for three different time intervals: Y0-15, Y0-25, and Y15-25. Univariate and multivariate Cox regression models (adjusted for age, sex, race, and traditional ASCVD risk factors) were used to determine the association of LDL-AUC (per 100 mg/dL x years) with incident fatal and non-fatal ASCVD events with mean follow-up time 19.1 years after Y15 and 9.7 years after Y25. Logistic regression was used to measure the association of LDL-AUC with conversion from CAC=0 to CAC>0.

Results
Of those with CAC=0 at Y15 (58% female, mean age 40 years) and Y25 (65% female, mean age 50 years), the event rate was 2.8 and 3.0 per 1000 person-years, respectively. After multivariate adjustment, LDL-AUC[Y0-15] in individuals with CAC=0 at Y15 was not associated with a significant increase in risk for ASCVD events (HR 1.01, 95% CI: 0.97-1.05). LDL-AUC[Y0-25] was associated with a significantly increased risk for ASCVD events after multivariate adjustment in those with persistent CAC=0 at Y25 (HR 1.05, 95% CI: 1.01-1.09). There was a significant association between LDL-AUC[Y15-25] and conversion from CAC=0 at Y15 to CAC>0 at Y25 (OR 1.10, 95% CI: 1.05-1.14).

Conclusions
In young adults with CAC=0, long-term cumulative exposure to LDL-C remains independently associated with a significant increase in ASCVD events and development of future CAC. While the risk of cardiovascular events is low for those with CAC=0, risk is detectable over longer exposure to greater cumulative LDL-C, confirming the continued importance of long-term LDL-C control.
  • Peng, Allison  ( Johns Hopkins School of Medicine , Baltimore , Maryland , United States )
  • Blaha, Michael  ( Johns Hopkins School of Medicine , Baltimore , Maryland , United States )
  • Blumenthal, Roger  ( Johns Hopkins School of Medicine , Baltimore , Maryland , United States )
  • Gianos, Eugenia  ( Northwell Health, Lenox Hill Hospital , New York , New York , United States )
  • Razavi, Alexander  ( Emory University , Atlanta , Georgia , United States )
  • Bimal, Tia  ( Northwell Health, Lenox Hill Hospital , New York , New York , United States )
  • Rubin, Maya  ( Northwell Health, Lenox Hill Hospital , New York , New York , United States )
  • Allen, Norrina  ( Northwestern University , Chicago , Illinois , United States )
  • Wilkins, John  ( Northwestern University , Chicago , Illinois , United States )
  • Sperling, Laurence  ( Emory University , Atlanta , Georgia , United States )
  • Rana, Jamal  ( Kaiser Permanente Northern California , Oakland , California , United States )
  • Whelton, Seamus  ( Johns Hopkins School of Medicine , Baltimore , Maryland , United States )
  • Author Disclosures:
    Allison Peng: DO NOT have relevant financial relationships | Michael Blaha: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bayer:Active (exists now) ; Advisor:New Amsterdam:Expected (by end of conference) ; Advisor:Vectura:Past (completed) ; Advisor:Agepha:Active (exists now) ; Advisor:Astra Zeneca:Past (completed) ; Advisor:Eli Lilly:Active (exists now) ; Advisor:Boehringer Ingelheim:Active (exists now) ; Advisor:Roche:Past (completed) ; Advisor:Merck:Past (completed) ; Advisor:Bayer:Active (exists now) ; Advisor:Novartis:Active (exists now) ; Advisor:Novo Nordisk:Active (exists now) ; Researcher:Amgen:Past (completed) | Roger Blumenthal: DO NOT have relevant financial relationships | Eugenia Gianos: DO have relevant financial relationships ; Speaker:Kaneka:Past (completed) ; Speaker:Medaxiom:Past (completed) | Alexander Razavi: DO NOT have relevant financial relationships | Tia Bimal: DO NOT have relevant financial relationships | Maya Rubin: No Answer | Norrina Allen: DO NOT have relevant financial relationships | John Wilkins: DO have relevant financial relationships ; Consultant:3M:Active (exists now) | Laurence Sperling: DO NOT have relevant financial relationships | Jamal Rana: DO NOT have relevant financial relationships | Seamus Whelton: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Preventive Strategies for Cardiovascular Disease from Childhood to Adulthood

Sunday, 11/17/2024 , 09:30AM - 10:55AM

Moderated Digital Poster Session

More abstracts from these authors:
Traditional Risk Factors, Cardiovascular Health, and Elevated Lipoprotein(a): The Multi-Ethnic Study of Atherosclerosis

Razavi Alexander, Reyes Mikaila, Wilkins John, Szklo Moyses, Tsai Michael, Whelton Seamus, Sperling Laurence, Tsimikas Sotirios, Bhatia Harpreet

Prevalence and Burden of Coronary Artery Calcium Across the Pooled Cohort Equation versus the American Heart Association PREVENT Risk Calculator

Gershon Gabrielle, Van Assen Marly, Razavi Alexander, Yang Yan, Dzaye Omar, Whelton Seamus, Blaha Michael, Blumenthal Roger, Sperling Laurence, De Cecco Carlo

You have to be authorized to contact abstract author. Please, Login
Not Available